Article
Current practice of cancer predisposition testing in pediatric patients with CNS tumors in the United States.
Pediatric blood & cancer - 1 Jan 2024
Roy Baylee, Knapke Sara, Pillay-Smiley Natasha, Zhang Xue, Queen Kate, Sisson Rebecca
Abstract excerpt
An estimated 8.6% of all pediatric patients with central nervous system tumors (CNSTs) have underlying hereditary cancer predisposition (HCP). Identifying HCP affects risk assessment and medical management options for the patients and their family members. However, there is a lack of consensus on the optimal germline genetic testing (GT) approach for pediatric patients with CNSTs. As a first step in addressing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
